Benefit of technetium-99m galactosyl human serum albumin scintigraphy instead of indocyanine green test in patients scheduled for hepatectomy

Hepatology Research

Volumn 44, Issue 10, 2014, Pages E118-E128

  Ohkura, Yasuo ^a   Mizuno, Shugo ^a   Kishiwada, Masashi ^a   Hamada, Takashi ^a   Usui, Masanobu ^a   Sakurai, Hiroyuki ^a   Tabata, Masami ^a   Yamada, Tomomi ^a   Isaji, Shuji ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatic functional reserve; ICGR15; LHL15; Liver failure

Indexed keywords

ALBUMIN; HUMAN SERUM ALBUMIN TC 99M; HYALURONIC ACID; INDOCYANINE GREEN;

AGED; ARTICLE; ASPHYXIA; BILE DUCT CARCINOMA; BILE DUCT INTRADUCTAL PAPILLARY NEOPLASM; BILE DUCT STONE; CAUSE OF DEATH; CONTROLLED STUDY; ELECTRONIC MEDICAL RECORD; FEMALE; GALLBLADDER CARCINOMA; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER HEMANGIOMA; LIVER METASTASIS; LIVER RESECTION; LIVER SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; PERIHILAR CHOLANGIOCARCINOMA; PNEUMONIA; PORTAL VEIN INJURY; PORTAL VEIN THROMBOSIS; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RETROSPECTIVE STUDY; SEPSIS; TUMOR RECURRENCE; VEIN INJURY;

EID: 84907874356     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12248     Document Type: Article

References (31)

1. Cherrick GR, Stein SW, Leevy CM, Davidson CS. Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction. J Clin Invest 1960; 39: 592-600.
2. Makuuchi M, Kosuge T, Takayama T etal. Surgery for small liver cancers. Semin Surg Oncol 1993; 9: 298-304.
3. Marshall JS, Green AM, Pensky J, Williams S, Zinn A, Carlson DM. Measurement of circulating desialylated glycoproteins and correlation with hepatocellular damage. J Clin Invest 1974; 54: 555-562.
4. Sawamura T, Kawasato S, Shiozaki Y, Sameshima Y, Nakada H, Tashiro Y. Decrease of a hepatic binding protein specific for asialoglycoproteins with accumulation of serum asialoglycoproteins in galactosamine-treated rats. Gastroenterology 1981; 81: 527-533.
5. Kudo M, Todo A, Ikekubo K, Hino M. Receptor index via hepatic asialoglycoprotein receptor imaging: correlation with chronic hepatocellular damage. Am J Gastroenterol 1992; 87: 865-870.
6. Kwon AH, Ha-Kawa SK, Uetsuji S, Inoue T, Matsui Y, Kamiyama Y. Preoperative determination of the surgical procedure for hepatectomy using technetium-99m-galactosyl human serum albumin (99mTc-GSA) liver scintigraphy. Hepatology 1997; 25: 426-429.
7. Hwang EH, Taki J, Shuke N etal. Preoperative assessment of residual hepatic functional reserve using 99mTc-DTPA-galactosyl-human serum albumin dynamic SPECT. J Nucl Med 1999; 40: 1644-1651.
8. Nanashima A, Yamaguchi H, Shibasaki S etal. Relationship between indocyanine green test and technetium-99m galactosyl serum albumin scintigraphy in patients scheduled for hepatectomy: clinical evaluation and patient outcome. Hepatol Res 2004; 28: 184-190.
9. Ebata T, Kamiya J, Nishio H, Nagasaka T, Nimura Y, Nagino M. The concept of perihilar cholangiocarcinoma is valid. Br J Surg 2009; 96: 926-934.
10. Das BC, Isaji S, Kawarada Y. Analysis of 100 consecutive hepatectomies: risk factors in patients with liver cirrhosis or obstructive jaundice. World J Surg 2001; 25: 266-273.
11. Kubota K, Makuuchi M, Kusaka K etal. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 1997; 26: 1176-1181.
12. Kawamura H, Kamiyama T, Nakagawa T etal. Preoperative evaluation of hepatic functional reserve by converted ICGR15 calculated from Tc-GSA scintigraphy. J Gastroenterol Hepatol 2008; 23: 1235-1241.
13. Ikai I, Kudo M, Arii S etal. Report of the 18th follow-up survey of primary liver cancer in Japan. Hepatol Res 2010; 40: 1043-1059.
14. Nagino M, Kamiya J, Nishio H, Ebata T, Arai T, Nimura Y. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg 2006; 243: 364-372.
15. Caesar J, Shaldon S, Chiandussi L, Guevara L, Sherlock S. The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin Sci 1961; 21: 43-57.
16. Leevy CM, Mendenhall CL, Lesko W, Howard MM. Estimation of hepatic blood flow with indocyanine green. J Clin Invest 1962; 41: 1169-1179.
17. Fujioka H, Kawashita Y, Kamohara Y etal. Utility of technetium-99m-labeled-galactosyl human serum albumin scintigraphy for estimating the hepatic functional reserve. J Clin Gastroenterol 1999; 28: 329-333.
18. Mimura T, Hamazaki K, Sakai H, Tanaka N, Mimura H. Evaluation of hepatic functional reserve in rats with obstructive jaundice by asyaloglycoprotein receptor. Hepatogastroenterology 2001; 48: 777-782.
19. Kokudo N, Vera DR, Tada K etal. Predictors of successful hepatic resection: prognostic usefulness of hepatic asialoglycoprotein receptor analysis. World J Surg 2002; 26: 1342-1347.
20. Yachida S, Wakabayashi H, Okano K, Suzuki Y. Prediction of posthepatectomy hepatic functional reserve by serum hyaluronate. Br J Surg 2009; 96: 501-508.
21. Shimada M, Matsumata T, Adachi E, Itasaka H, Watiyama S, Sugimachi K. Estimation of degree of liver cirrhosis using a fibrosis score; a multivariate analysis of clinical parameters and resected specimens. Hepatogastroenterology 1994; 41: 177-180.
22. Kajiwara E, Akagi K, Azuma K, Onoyama K, Fujishima M. Evidence for an immunological pathogenesis of thrombocytopeniain chronic liver disease. Am J Gastroenterol 1995; 90: 962-966.
23. Kusaka K, Harihara Y, Torzilli G etal. Objective evaluation of liver consistency to estimate hepatic fibrosis and functional reserve for hepatectomy. J Am Coll Surg 2000; 191: 47-53.
24. Kamohara Y, Takatsuki M, Hidaka M, Soyama A, Kanematsu T, Eguchi S. 99mTc-Galactosyl sialyl albumin (GSA) scintigram adjusts hepatic resection range in ICG based estimation. Hepatogastroenterology 2011; 58: 2058-2061.
25. Kira T, Tomiguchi S, Takahashi M, Yoshimatsu S, Sagara K, Kurano R. Correlation of 99mTc-GSA hepatic scintigraphy with liver biopsies in patients with chronic active hepatitis type C. Radiat Med 1999; 17: 125-130.
26. Dhillon AP, Dusheiko GM. Pathology of hepatitis C virus infection. Histopathology 1995; 26: 297-309.
27. Scheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko GM. The pathology of hepatitis C. Hepatology 1992; 15: 567-571.
28. Lefkowitch JH, Schiff ER, Davis GL etal. Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group. Gastroenterology 1993; 104: 595-603.
29. Kim YK, Nakano H, Yamaguchi M etal. Prediction of postoperative decompensated liver function by technetium-99m galactosyl-human serum albumin liver scintigraphy in patients with hepatocellular carcinoma complicating chronic liver disease. Br J Surg 1997; 84: 793-796.
30. Loehrer AP, House MG, Nakeeb A, Kilbane EM, Pitt HA. Cholangiocarcinoma: are North American surgical outcomes optimal? J Am Coll Surg 2013; 216: 192-200.
31. Yokoyama Y, Nishio H, Ebata T, Igami T, Sugawara G, Nagino M. Value of indocyanine green clearance of the future liver remnant in predicting outcome after resection for biliary cancer. Br J Surg 2010; 97: 1260-1268.